Femasys (FEMY)
(Delayed Data from NSDQ)
$1.09 USD
-0.03 (-2.68%)
Updated Sep 17, 2024 04:00 PM ET
After-Market: $1.09 0.00 (0.00%) 7:02 PM ET
4-Sell of 5 4
F Value D Growth D Momentum F VGM
Femasys Inc. (FEMY) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$8.33 | $12.00 | $3.00 | 643.75% |
Price Target
Based on short-term price targets offered by three analysts, the average price target for Femasys Inc. comes to $8.33. The forecasts range from a low of $3.00 to a high of $12.00. The average price target represents an increase of 643.75% from the last closing price of $1.12.
Analyst Price Targets (3 )
Broker Rating
Femasys Inc. currently has an average brokerage recommendation (ABR) of 1.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by three brokerage firms. The current ABR compares to an ABR of 1.00 a month ago based on three recommendations.
Of the three recommendations deriving the current ABR, three are Strong Buy, representing 100% of all recommendations. A month ago, Strong Buy represented 100%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 3 | 3 | 3 | 3 | 3 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
8/14/2024 | Chardan Capital Markets | Keay T Nakae | Strong Buy | Strong Buy |
7/8/2024 | Maxim Group | Jason Mccarthy | Strong Buy | Strong Buy |
6/20/2024 | H.C. Wainwright & Co. | Emily Bodnar | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.00 |
ABR (Last week) | 1.00 |
# of Recs in ABR | 3 |
Average Target Price | $8.33 |
LT Growth Rate | NA |
Industry | Medical - Biomedical and Genetics |
Industry Rank by ABR | 79 of 253 |
Current Quarter EPS Est: | -0.20 |
FEMY FAQs
Femasys Inc. (FEMY) currently has an average brokerage recommendation (ABR) of 1.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 3 brokerage firms.
The average price target for Femasys Inc. (FEMY) is $8.33. The current on short-term price targets is based on 2 reports.
The forecasts for Femasys Inc. (FEMY) range from a low of $3 to a high of $12. The average price target represents a increase of $643.75 from the last closing price of $1.12.
The current UPSIDE for Femasys Inc. (FEMY) is 643.75%
Based on short-term price targets offered by three analysts, the average price target for Femasys Inc. comes to $8.33. The forecasts range from a low of $3.00 to a high of $12.00. The average price target represents an increase of 643.75% from the last closing price of $1.12.